Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of VIGO is 0.8% (low). The 2025 annual accounts show equity of €10.91M and a net result of €8.27M. Equity remains stable across the filed fiscal years (±1.3% per year). Its solvency ranks better than 31% of 73 sector peers (fiscal year 2025). The company has been active since 1991 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 5 annual accounts.
Trust signals
2 signalsLong-established
Founded in 1991, 35 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.8%
Low
0%0,5%1,5%4%10%≥25%
Multiple establishment units
+Long track record
−Annual accounts: healthy financial profile
−
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Turnover€107.74M+40.2%
EBIT margin11.2%+0.7pp
Net result€8.27M+41.8%
Working capital€15.00M+27.4%
Annual accounts & ratios
Source: NBB · 2025Annual accounts filed on 12-06-2026 with the NBB · fiscal year 2025 · volledig
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
stable
Equity: stable across 5 fiscal years (±1.3%/year).
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 32 · compared across all schema types (micro, abbreviated and full combined)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 16.0% | 33.0% | |
| Net result | €8.27M | €12k | |
| Equity | €10.91M | €38k | |
| Total assets | €68.08M | €195k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
P31
Weakening position over 2020-2025
· n=60-157
P95
Stable position over 2020-2025
· n=60-156
P95
Stable position over 2020-2025
· n=60-157
P95
Stable position over 2020-2025
· n=60-157
Describes the position versus peers, not a forecast.
€107.74M
+40.2%
+212% vs sector
€16.33M
+43.0%
far above sector median
€8.27M
+41.8%
far above sector median
€12.56M
+36.3%
far above sector median
€68.08M
+18.7%
far above sector median
€10.91M
-62.6%
far above sector median
€15.00M
+27.4%
far above sector median
516
+26.5%
far above sector median
€38.04M
+36.0%
far above sector median
€2.67M
+29.1%
far above sector median
€8.00M
-28.6%
+111% vs sector
€57.17M
+103.2%
far above sector median
€36.12M
+29.1%
far above sector median
€21.05M
+12792.5%
far above sector median
1.42
-0.4%
-14% vs sector
1.17
-1.2%
≈ vs sector
16.0%
-68.5%
-72% vs sector
5.24
+444.0%
far above sector median
75.8%
+279.8%
far above sector median
12.1%
+19.5%
+24% vs sector
7.7%
+1.2%
+11% vs sector
15.2%
+2.0%
+19% vs sector
10.46
-56.8%
-83% vs sector
Figures by fiscal year
| Fiscal year | 2025 |
|---|---|
| Revenue | €107.74M |
| EBITDA | €16.33M |
| Net profit | €8.27M |
| Cash flow | €12.56M |
| Staff costs | €38.04M |
| Income taxes | €2.67M |
| Dividends | €8.00M |
| Total assets | €68.08M |
| Equity | €10.91M |
| Debt | €57.17M |
| of which ≤ 1y | €36.12M |
| of which > 1y | €21.05M |
| Working capital | €15.00M |
| Employees (FTE) | 516.0 |
Ratios (computed)
| 2025 | |
|---|---|
| Current ratio | 1.42 |
| Quick ratio | 1.17 |
| Working capital ratio | 22.0% |
| Solvency | 16.0% |
| Debt / equity | 5.24 |
| Long-term debt ratio | 1.93 |
| Interest coverage | 10.46 |
| Gross margin | 69.5% |
| Net margin | 7.7% |
| ROA | 12.1% |
| ROE | 75.8% |
| EBITDA margin | 15.2% |
| Days sales outstanding | 105d |
| Days payable outstanding | 130d |
| Inventory turnover | 3.73 |
| Days inventory (DSI) | 98d |
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €68.08M |
| Fixed assets | 21/28 | €16.97M |
| Intangible fixed assets | 21 | €7.04M |
| Tangible fixed assets | 22/27 | €9.88M |
| Financial fixed assets | 28 | €45k |
| Current assets | 29/58 | €51.12M |
| Stocks & contracts in progress | 3 | €8.80M |
| Amounts receivable within one year | 40/41 | €40.18M |
| Cash & bank | 54/58 | €1.74M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €68.08M |
| Equity | 10/15 | €10.91M |
| Contributions / capital | 10/11 | €2.71M |
| Reserves | 13 | €8.19M |
| Accumulated profits (losses) | 14 | €0 |
| Provisions & deferred taxes | 16 | €6k |
| Amounts payable | 17/49 | €57.17M |
| Amounts payable after one year | 17 | €21.05M |
| Amounts payable within one year | 42/48 | €36.12M |
| Trade debts payable within one year | 44 | €11.72M |
| Income statement | ||
| Turnover | 70 | €107.74M |
| Operating result | 9901 | €12.04M |
| Financial income | 75 | €512k |
| Financial charges | 65 | €1.61M |
| Result before taxes | 9903 | €10.94M |
| Income taxes | 67/77 | €2.67M |
| Net result for the period | 9904 | €8.27M |
| Result to be appropriated | 9905 | €8.27M |
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2025 · computed81
/ 100
Excellent
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.
Directors
Directors & mandates
30 directorsHistoric, not recently confirmed (20)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
-
Not recently confirmedlast confirmed in an act from 2020
-
Not recently confirmedlast confirmed in an act from 2020
3 events
- 01-03-2020 Resigned· Director
- 01-03-2020 Appointed· Managing director
- 04-11-2019 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2020
-
Not recently confirmedlast confirmed in an act from 2020
-
Not recently confirmedlast confirmed in an act from 2020
2 events
- 01-03-2020 Appointed· Director
- 01-03-2020 Appointed· Managing director
-
Not recently confirmedlast confirmed in an act from 2019
-
L&J-LABEL BVBALegal entityManaging director· perm. rep.: Jan RuysschaertState Gazette act 19167053 (24-12-2019)Not recently confirmedlast confirmed in an act from 2019
-
Not recently confirmedlast confirmed in an act from 2019
3 events
- 24-12-2019 Mandate renewed· Director
- 07-08-2014 Mandate renewed· Director
- 02-02-2004 Appointed· Director
-
Vigo International NVLegal entityDirector· perm. rep.: Jan RuysschaertState Gazette act 18014212 (19-01-2018)Not recently confirmedlast confirmed in an act from 2018
2 events
- 01-01-2018 Appointed· Director
- 01-01-2018 Appointed· Managing director
-
Not recently confirmedlast confirmed in an act from 2008
-
VC ProjectsLegal entityDirector· perm. rep.: Stefan VuylstekeState Gazette act 08118524 (16-07-2008)Not recently confirmedlast confirmed in an act from 2008
-
BVBA K.M.O.-AviesLegal entityDirector· perm. rep.: Nele VanhouteghemState Gazette act 08116478 (14-07-2008)Not recently confirmedlast confirmed in an act from 2008
-
Comm.VA C.E.R.Legal entityDirector· perm. rep.: Jan RuysschaertState Gazette act 08116478 (14-07-2008)Not recently confirmedlast confirmed in an act from 2008
2 events
- 20-06-2008 Mandate renewed· Director
- 20-06-2008 Appointed· Managing director
-
Luna Consulting BVBALegal entityDirector· perm. rep.: Luc NAESSENSState Gazette act 08116478 (14-07-2008)Not recently confirmedlast confirmed in an act from 2008
+ 6 not shown in this overview
Former directors (10)
-
Former01-03-2020 → 17-02-2022
3 events
- 17-02-2022 Resigned· Director
- 01-03-2020 Appointed· Director
- 01-03-2020 Appointed· Managing director
-
Former01-03-2020 → 17-02-2022
3 events
- 17-02-2022 Resigned· Director
- 01-03-2020 Appointed· Director
- 01-03-2020 Appointed· Managing director
-
S. Van HeckeLegal entityDirector· perm. rep.: Steve Van HeckeState Gazette act 20047173 (06-04-2020)Former01-03-2020 → 17-02-2022
3 events
- 17-02-2022 Resigned· Director
- 01-03-2020 Appointed· Director
- 01-03-2020 Appointed· Managing director
-
TWINCLegal entityDirector· perm. rep.: Titia WillemsState Gazette act 22021909 (17-02-2022)Former- → 17-02-2022
-
K.M.O. ADVIESLegal entityDirector· perm. rep.: Nele VanhouteghemState Gazette act 19167053 (24-12-2019)Former24-12-2019 → 01-03-2020
2 events
- 01-03-2020 Resigned· Director
- 24-12-2019 Mandate renewed· Director
-
Vigo Group NVLegal entityDirector· perm. rep.: Jan RuysschaertState Gazette act 18014212 (19-01-2018)Former- → 01-01-2018
2 events
- 01-01-2018 Resigned· Director
- 01-01-2018 Resigned· Managing director
-
C.E.R. - CLINICAL ENGINEERING & RESEARCHLegal entityDirector· perm. rep.: Jan RuysschaertState Gazette act 04017038 (02-02-2004)Former02-02-2004 → 30-06-2014
3 events
- 30-06-2014 Resigned· Managing director
- 02-02-2004 Mandate renewed· Director
- 02-02-2004 Mandate renewed· Managing director
-
De Wilde J ManagementLegal entityDirector· perm. rep.: Julien De WildeState Gazette act 14212272 (25-11-2014)Former- → 16-06-2008
-
Former- → 16-06-2008
-
Former- → 02-02-2004
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
5 auditors| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| KPMG Réviseurs d'EntreprisesCurrent Statutory auditor · represented by Wim Heyndrickx |
- | 01-01-2023 → present |
| BDO Bedrijfsrevisoren Burg. Ven. CVBA Statutory auditor · represented by Erik Thuysbaert succeeded by PWC Bedrijfsrevisoren BCVBA in 2018 |
- | 10-08-2015 → 27-07-2018 |
| Ernst et Young Reviseurs d'Entreprises Statutory auditor · represented by Lieve Cornelis succeeded by KPMG Réviseurs d'Entreprises in 2023 |
- | 01-01-2020 → 01-01-2023 |
| Pwc Bedrijfsrevisoren Statutory auditor · represented by Peter Opsomer succeeded by KPMG Réviseurs d'Entreprises in 2023 |
- | 01-12-2018 → 01-01-2023 |
| PWC Bedrijfsrevisoren BCVBA Statutory auditor · represented by Filip Drieghe succeeded by Ernst et Young Reviseurs d'Entreprises in 2020 |
- | 27-07-2018 → 01-01-2020 |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden(32500) |
| Legal form | Public limited company(014) |
| Incorporation | 12-06-1991 |
| Status | Active |
| Postal code | 9230 |
Structure & network
Connections & network
14 connected companiesGroup structure
Parent · 1 subsidiary · 1 location
Control→
Parent · 3 subsidiaries · 1 location
Control→
Parent · 926 subsidiaries · 5 locations
Control→
Parent · 1 subsidiary · 2 locations
Control→
Parent · 2 subsidiaries · 1 location
Control→
Parent · 419 subsidiaries · 7 locations
Control→
Parent · 3 subsidiaries · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Parent · 3 subsidiaries · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Parent · 3 subsidiaries · 1 location
Control→
Parent · 1 subsidiary · 1 location
Control→
Network connections
Shared corporate director
→
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Locations & real estate
Registered office
on the map · from the address register
seat.Municipality
exact location from the address register
Establishment units
17 locationsCampus CTO Pellenberg
since 19912.053.314.311
Campus CTO Gent
since 19932.064.897.792
Campus CTO
since 19992.064.897.693
Campus Cebelor
since 20112.201.013.241
Campus Cebelor Namur
since 20112.201.014.429
Campus CTO UZ Gent
since 20112.201.016.013
Campus Ortec
since 20112.201.010.172
Campus Ortec Tienen
since 20112.201.011.162
V!GO Campus MM Deurne
since 20142.224.926.117
V!GO Campus Antwerpen Zuid
since 20162.259.374.379
Campus Gasthuisberg
since 20192.283.948.142
Campus Sterrebeek
since 20212.311.196.036
Campus Roeselare
since 20212.320.288.894
VIGO Campus Deurne Winkel
since 20222.325.307.061
Campus Turnhout
since 20232.340.385.316
Campus Hasselt
since 20252.369.945.966
Campus Genk
since 20252.369.946.065
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels17
Ground area49.1 ha
Buildings17
Building footprint9.6 ha
Volume (LiDAR)936,149 m³
Tallest building34.3 m · ±6 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
16
(94.1%)
Wallonia
1
(5.9%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24505K0046/00H004 | Flanders | 42.5 ha | 1 · 6.4 ha | 34.2 m · 3 fl. |
| 42025G0818/00F000 | Flanders | 1.1 ha | 1 · 2,653 m² | 9.4 m · 3 fl. |
| 24514C0087/00A000 | Flanders | 1.0 ha | 1 · 1,667 m² | 11.4 m · 3 fl. |
| 24090C0184/00E000 | Flanders | 9,149 m² | 1 · 8,547 m² | 34.2 m · 6 fl. |
| 11345B0223/00F005 | Flanders | 8,821 m² | 1 · 1.2 ha | - |
| 92039A0089/00X002 | Wallonia | 7,919 m² | 1 · 394 m² | 12.1 m · 3 fl. |
| 71328D0501/00D000 | Flanders | 6,292 m² | 1 · 1,035 m² | - |
| 71304E0724/00V015 | Flanders | 4,487 m² | 1 · 1,234 m² | 8.9 m · 2 fl. |
| 23095C0033/00G004 | Flanders | 3,335 m² | 1 · 637 m² | 10.4 m · 2 fl. |
| 11462A0169/00R007 | Flanders | 1,345 m² | 1 · 924 m² | 11.8 m · 3 fl. |
7 more parcels, available with Plus.
See plans →Methodology
via registered seat: 1 · via establishment units: 16
17 of 17 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgian State Gazette · acts
51 verified actsWhat every Belgian State Gazette publication actually says, each act broken down into appointments, capital movements, seat moves and statute amendments.
2026
19-03-2026
Resignations & appointments
- General meeting , 02/06/2025
- Board meeting , 02/06/2025
- Director reappointment, M.M.C. BV (bestuurder)
- Director reappointment, S. VAN HECKE BV (bestuurder)
- Director reappointment, ELODUS BV (bestuurder)
- Director reappointment, TWINC BV (bestuurder)
+9 further facts
2025
24-01-2025
Capital & shares · Restructuring
- General meeting , 30/12/2024
- Merger , verrichting gelijkgesteld met fusie door overneming, 30/12/2024
- Accounting effect , 01/11/2024
- Capital increase , €24.800
- Capital , €2.701.800
- Power of attorney, RVH-Notarissen
+1 further fact
24-01-2025
Capital & shares · Restructuring
- General meeting , 30/12/2024
- Merger , verrichting gelijkgesteld met fusie door overneming, 30/12/2024
- Accounting effect , 01/10/2024
- Capital increase , €65.000
- Capital , €2.677.000
- Power of attorney, Julie Vanermen
+2 further facts
2024
25-11-2024
Restructuring
- Merger , vereenvoudigde zusterfusie
- Accounting effect , 01/11/2024
- Corporate purpose , De vennootschap heeft als voorwerp, zowel in België als in het buitenland, voor eigen rekening of voor rekening van derden, al dan niet onrechtstreeks door midd…
- Corporate purpose , De vennootschap heeft tot voorwerp voor eigen rekening of voor rekening van derden, in eigen naam of als tussenpersoon of commissionair: a) de fabricatie en all…
- Real estate , Een handelspand met grond en alle verdere aanhorigheden, staande en gelegen te 3600 Genk, Henry Fordlaan 43 (gekend in het kadester onder: Genk, 4° afdeling Sec…
- Power of attorney, Louis Clarys
+13 further facts
25-11-2024
Restructuring
- Merger , vereenvoudigde zusterfusie
- Accounting effect , 01/10/2024
- Corporate purpose , De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, voor eigen rekening of voor rekening van derden, of door deelname van dezen: 1/ Het k…
- Corporate purpose , De vennootschap heeft tot voorwerp voor eigen rekening of voor rekening van derden, in eigen naam of als tussenpersoon of commissionair: a) de fabricatie en all…
- Power of attorney, Louis Clarys
- Power of attorney, Louis Clarys
04-03-2024
Resignations & appointments
- General meeting , 22/01/2024
- Auditor appointment, KPMG Bedrijfsrevisoren BV (commissaris)
- Mandate compensation, KPMG Bedrijfsrevisoren BV
2022
17-02-2022
Capital & shares · Resignations & appointments · Restructuring
- General meeting , 10/01/2022
- Merger , 10/01/2022
- Dissolution , 2022-01-10
- Accounting effect , 31/12/2021
- Corporate purpose , het vervaardigen van allerhande prothesen en orthopedisch materiaal en aanverwante activiteiten
- Permanent representative, Michiel Meerbergen
+8 further facts
2021
22-11-2021
Restructuring
- Merger
- Accounting effect , 01/01/2022
- Corporate purpose , De vennootschap heeft tot voorwerp voor eigen rekening of voor rekening van derden, in eigen naam of als tussenpersoon of commissionair: a)de fabrícatie en alle…
- Corporate purpose , De vennootschap heeft tot voorwerp: Alle verrichtingen die verbintenissen scheppen, wijzígen of teniet doen in verband met medische en paramedische apparaten en…
- Real estate , Een handelseigendom op en met grond en alle verdere aanhorigheden, staande en gelegen te 2100 Antwerpen-district Deurne, Herentalsebaan 414, thans ten kadaster…
- Real estate , Een handelshuis op en met grond en aanhorigheden, staande en gelegen te Antwerpen (Deurne), Herentalsebaan 416, thans ten kadaster gekend wijk B nummer 437/D/9…
+4 further facts
24-02-2021
Restructuring
- General meeting , 08/01/2021
- Merger , 08/01/2021
- Dissolution , 2021-01-08
- Accounting effect , 31/12/2020
- Corporate purpose , vervaardigen van allerhande prothesen en orthopedisch materiaal en aanverwante activiteiten
- Power of attorney, Olivier Van Maele
+1 further fact
24-02-2021
Restructuring
- General meeting , 08/01/2021
- Merger , 08/01/2021
- Dissolution , 2021-01-08
- Accounting effect , 31/12/2020
- Power of attorney, Olivier Van Maele
- Power of attorney, Julie Vanermen
+1 further fact
18-01-2021
Resignations & appointments
- General meeting , 26/06/2020
- Auditor appointment, EY Bedrijfsrevisoren BV
2020
10-11-2020
Restructuring
- Merger , geruisloze fusie
- Accounting effect , 01/01/2021
- Corporate purpose , De vennootschap heeft tot doel: De productie en handel zowel in groothandel als detailhandel, import en export van alle orthopedische en paramedische toestellen…
- Corporate purpose , De vennootschap heefttotvoorwerp voor eigen rekening of voor rekening van derden, in eígen naam of als tussenpersoon of commissionair: a) de fabricatie en alle…
- Power of attorney, e12, e13, e14, e15
- Power of attorney, e12, e13, e14, e15
+7 further facts
Show 12 older acts
What every Belgian State Gazette publication actually says, each act broken down into appointments, capital movements, seat moves and statute amendments.
2020
10-11-2020
Restructuring
- Merger , geruisloze fusie
- Accounting effect , 01/01/2021
- Corporate purpose , De vennootschap heeft tot voorwerp, in België of in het buitenland, hetzij rechtstreeks, hetzij als tussenpersoon, uitsluitend in eigen naam en voor eigen reken…
- Corporate purpose , De vennootschap heeft tot voorwerp voor eigen rekening of voor rekening van derden, in eigen naam of als tussenpersoon of commissionair: a) de fabricatie en all…
- Permanent representative, dr. Steve Van Hecke
- Permanent representative, dr. Michiel Meerbergen
+3 further facts
06-04-2020
Statutes amendment · Resignations & appointments
- General meeting , 12/03/2020
- Statutes amendment
- Accounting effect , 01/03/2020
- Corporate purpose , De vennootschap heeft tot voorwerp voor eigen rekening of voor rekening van derden, in eigen naam of als tussenpersoon of commissionair: a) de fabricatie en all…
- Capital , €2.612.000
- Director resignation, VIGO INTERNATIONAL (bestuurder)
+24 further facts
2019
24-12-2019
Resignations & appointments
- General meeting , 07/06/2019
- Director reappointment, Hendrikus Van Der Meulen (bestuurder)
- Director reappointment, EVORA BVBA (bestuurder)
- Director reappointment, KMO ADVIES BVBA (bestuurder)
26-11-2019
Resignations & appointments
- General meeting , 04/11/2019
- Director resignation, Evora BVBA (bestuurder)
- Permanent representative, Daniel Vandeven
- Director resignation, Hendrikus van der Meulen (bestuurder)
- Director appointment, Michiel Meerbergen (bestuurder)
- Mandate compensation, Michiel Meerbergen
24-04-2019
Restructuring
- General meeting , 26/03/2019
- Merger , absorption, overdracht van gehele vermogen
- Accounting effect , 28/02/2019
- Power of attorney, raad van bestuur
- Share concentration , ja
28-01-2019
Restructuring
- Board meeting , 10/01/2019
- Merger
- Accounting effect , 28/02/2019
- Target approval date , 30/06/2019
16-01-2019
Statutes amendment
- Statutes amendment
- Statutes amendment
- Corporate purpose , a) de fabricatie en alle verrichtingen die rechtstreeks of onrechtstreeks betrekking hebben op het vervaardigen van artikelen voor orthopedie... b) de construct…
- Capital , €2.612.000
- Director appointment, V!GO International (A-bestuurder)
- Permanent representative, Jan Ruysschaert
+5 further facts
07-01-2019
Resignations & appointments
- General meeting , 17/12/2018
- Permanent representative, Peter Opsomer
- Power of attorney, Goedele Buekens
- Power of attorney, Peter Rooryck
2018
27-07-2018
Resignations & appointments
- General meeting , 12/06/2018
- Auditor appointment, BCVBA PwC Bedrijfsrevisoren (commissaris)
- Permanent representative, Filip Drieghe (vertegenwoordiger)
- Permanent representative, Jan Ruysschaert (vast vertegenwoordigd)
15-06-2018
Resignations & appointments
- General meeting , 31/05/2018
- Permanent representative, NOMAD Invest NV
- Permanent representative, Nele Vanhouteghem
01-02-2018
Statutes amendment
- General meeting , 18/12/2017
- Statutes amendment
- Power of attorney, raad van bestuur
- Certificate repurchase , VIGO GROUP, 7322
19-01-2018
Resignations & appointments
- General meeting , 22/12/2017
- Board meeting , 22/12/2017
- Director resignation, Vigo Group NV (bestuurder)
- Director resignation, Vigo Group NV (gedelegeerd bestuurder)
- Director appointment, Vigo International NV (bestuurder)
- Director appointment, Vigo International NV (gedelegeerd bestuurder)
+1 further fact
Showing the 24 most recent of 51 acts. Full history
Analysis
Snowflake analysis
financial profile on 5 axes74
/ 100
Strong profile, led by stability.
Health
81
Profitability
80
Solvency
31
Growth
78
Stability
100
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Credit advice
verdict per customer and amountSimilar
Similar companies
Largest companies in this sector: this company is among the largest, so we show the sector's topCompany registry
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Vervaardiging van orthopedische artikelen en prothesen33103Detailhandel in ICT-apparatuur47400Detailhandel in computers, randapparatuur en software in gespecialiseerde winkels47410Gespecialiseerde detailhandel in kantoormachines en -meubelen, computers en standaardprogrammatuur en telecommunicatieapparatuur52487
Primary activity highlighted.
Names & trade names
| Legal nameNL | VIGO |
Registered office
Biezeweg 13
9230 Wetteren, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.